SCHEMBL4077892

SCHEMBL4077892

OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.46
LMNA P02545 3/20 0.46
AOC3 Q16853 2/20 0.46
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
ADRA2C P18825 2/20 0.42
ADRA2A P08913 1/20 0.42
HIF1A Q16665 1/20 0.42
CHRM2 P08172 1/20 0.39
ADRA1A P35348 1/20 0.39
RGS12 O14924 1/20 0.39
GLA P06280 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5873439 1.00 TDP1 (0.50) TDP1L3MBTL1LMNAAOC3ALDH1A1
SCHEMBL27825950 1.00 TDP1 (0.50) TDP1L3MBTL1LMNAAOC3ALDH1A1
Alcohol SCHEMBL28032136 0.94 AOC3 (0.46) TDP1L3MBTL1LMNAAOC3ALDH1A1
SCHEMBL550791 0.91 AOC3 (0.48) TDP1L3MBTL1LMNAAOC3ALDH1A1
SCHEMBL551822 0.91 AOC3 (0.48) TDP1L3MBTL1LMNAAOC3ALDH1A1
SCHEMBL550790 0.91 AOC3 (0.48) TDP1L3MBTL1LMNAAOC3ALDH1A1
SCHEMBL3389900 0.91 AOC3 (0.48) TDP1L3MBTL1LMNAAOC3ALDH1A1
SCHEMBL117950 0.87 SLC6A2 (0.54) L3MBTL1LMNAAOC3ALDH1A1KDM4E
SCHEMBL30801376 0.87 SLC6A2 (0.54) L3MBTL1LMNAAOC3ALDH1A1KDM4E
SCHEMBL8075340 0.82 TDP1 (0.48) TDP1L3MBTL1LMNAAOC3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2076503-B1 C-PHENYL GLYCITOL COMPOUND FOR THE TREATMENT OF DIABETES TAISHO PHARMACEUTICAL CO LTD (JP) 2013-07-17 EP claimed
CN-119735586-A Engliflozin crystal form III and preparation method thereof 济南大学 2025-04-01 CN disclosed
CN-119080759-A Crystal form of acetylated enggliflozin and preparation method thereof 江苏阿尔法药业股份有限公司 2024-12-06 CN disclosed
WO-2022107463-A1 METHOD FOR PRODUCING KETONE DERIVATIVE 株式会社トクヤマ 2022-05-27 WO disclosed
WO-2022071578-A1 COMBINATIONAL MEDICINE OF MINERALOCORTICOID RECEPTOR ANTAGONIST AND SGLT2 INHIBITOR 第一三共株式会社 2022-04-07 WO disclosed
JP-2009120553-A THERAPEUTIC AGENT FOR DIABETES CONTAINING C-PHENYL GLUCITOL COMPOUND AS EFFECTIVE INGREDIENT TAISHO PHARMACEUTICAL CO LTD 2009-06-04 JP disclosed